CN Patent

CN116332905B — (s)-n-苯基-1-(吡啶-2-基)吡咯烷-2-甲酰胺衍生物

Assigned to Shanghai Yishi Pharmaceutical Technology Co ltd · Expires 2025-07-08 · 1y expired

What this patent protects

本发明涉及一种(S)‑N‑苯基‑1‑(吡啶‑2‑基)吡咯烷‑2‑甲酰胺衍生物及其在治疗和/或预防癌症上的用途，以及包含所述衍生物的组合物以及制备方法。

USPTO Abstract

本发明涉及一种(S)‑N‑苯基‑1‑(吡啶‑2‑基)吡咯烷‑2‑甲酰胺衍生物及其在治疗和/或预防癌症上的用途，以及包含所述衍生物的组合物以及制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN116332905B
Jurisdiction
CN
Classification
—
Expires
2025-07-08
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Yishi Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.